Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment

Coates, LC, Birt, J, Kronbergs, A et al. (4 more authors) (2021) Quality of life improvements in patients with PsA who achieve remission or low disease activity targets: results from two clinical trials of ixekizumab at three years of treatment. In: British Society for Rheumatology Annual Conference 2021, 26-28 Apr 2021, Virtual.

Metadata

Item Type: Conference or Workshop Item
Authors/Creators:
Dates:
  • Published: April 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 13 Oct 2021 15:24
Last Modified: 13 Oct 2021 15:24
Status: Published
Identification Number: 10.1093/rheumatology/keab247.167
Related URLs:
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics


CORE (COnnecting REpositories)